Showing 2,796 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP programmes & uptake

DSD in Action: Innovative PrEP delivery for men who have sex with men in the Philippines

Editor's pick
Differentiated Service Delivery
2 October 2023
PrEP policies & guidelines

PrEP care becomes available to everyone at risk of HIV in the Netherlands

Editor's pick
NL Times
28 September 2023
PrEP science

PrEP use in pregnancy doesn't raise the risk of adverse pregnancy or birth outcomes

News
22 September 2023
Injectable & long-acting PrEP

A shot prevents HIV, but those most in need struggle to access care

Editor's pick
Washington Post
21 September 2023
PrEP policies & guidelines

US: Primary Care Clinicians Should Spearhead HIV Prevention

Editor's pick
Medscape (requires free registration)
21 September 2023
Injectable & long-acting PrEP

European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention

Editor's pick
ViiV Healthcare
19 September 2023
Injectable & long-acting PrEP

Malaysia Approves First Long-Acting Injectable HIV Prevention Drug

Editor's pick
CodeBlue
15 September 2023
PrEP science

Users of TAF in PrEP more likely to develop high blood pressure or need statins

News
14 September 2023
PrEP programmes & uptake

Beauty salon-based intervention increases trust of PrEP among Black cisgender women

Editor's pick
EurekAlert!
14 September 2023
PrEP policies & guidelines

US: Why Don’t Insurance Plans Routinely Cover Pre-Exposure Prophylaxis (PrEP)?

Editor's pick
TheBodyPro
13 September 2023
Vaginal rings & topical PrEP

SwiftPharma and the Population Council pursue agreement to manufacture Griffithsin needed for the development of a fast-dissolving insert for protection against HIV

Editor's pick
EurekAlert!
13 September 2023
PrEP policies & guidelines

HIV Prevention Choice Manifesto for Women and Girls in Africa launched

Editor's pick
UNAIDS
13 September 2023
PrEP policies & guidelines

Two-thirds of countries in Latin America and the Caribbean offer PrEP

News
12 September 2023
Injectable & long-acting PrEP

Study: Price of long-acting PrEP ‘unrealistic’ for population-level HIV control

Editor's pick
Healio
11 September 2023
PrEP programmes & uptake

Chinese MSM need a multi-layered approach to improve PrEP uptake and adherence

News
1 September 2023
The search for an HIV prevention vaccine

A trial is underway that could be ‘the last roll of the dice’ for an HIV vaccine this decade

Editor's pick
CNN
28 August 2023
PrEP

Top 5 HIV PrEP stories from IAS 2023

News
25 August 2023
PrEP policies & guidelines

US: Insurers must cover injectable HIV prevention drug — unless courts void mandate

Editor's pick
NBC News
24 August 2023
Finance & funding

Thai key population-led organisations give hope for sustainable HIV financing

News
23 August 2023
Injectable & long-acting PrEP

MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA

Editor's pick
MSF Access Campaign
20 August 2023
Injectable & long-acting PrEP

Pharma Pricing Secrecy Runs Amok

Editor's pick
Health GAP (Global Access Project)
20 August 2023
PrEP policies & guidelines

Injectable PrEP requires new testing procedures, IAS conference hears

News
17 August 2023
PrEP

What do young people think of on-demand PrEP?

Editor's pick
Be In The Know
16 August 2023
PrEP science

Exposure to tenofovir-based PrEP in the womb does not affect children’s bone density

News
10 August 2023